Skip to main content

Thank you for visiting You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

Severe and prolonged hypophosphatemia after intravenous iron administration in a malnourished patient


Malnutrition may result in a phosphate-deficient state owing to a chronically insufficient phosphate intake. Concomitant iron deficiency is common and often supplemented by the intravenous route. It is not widely recognized that some parenteral iron formulations can induce hypophosphatemia. Herein we report a case of a severe and symptomatic hypophosphatemia (0.18 mM, normal range 0.8–1.4 mM) associated with an inappropriately reduced tubular reabsorption of phosphate (33%, norm >95%) in a malnourished patient with anorexia/bulimia who received 2 × 500 mg iron carboxymaltose (FCM) intravenously. Despite intravenous and oral phosphate supplements, it required 2 months to achieve a normal serum phosphate level. Our case demonstrates that in a chronically malnourished and phosphate-deficient state intravenous FCM could potentially be dangerous. If this form of iron application cannot be avoided, phosphate supplementation before and after iron infusion as well as close monitoring of phosphate levels are needed.

This is a preview of subscription content, access via your institution

Relevant articles

Open Access articles citing this article.

Access options

Rent or buy this article

Prices vary by article type



Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2


  1. Van Wyck DB, Mangione A, Morrison J, Hadley PE, Jehle JA, Goodnough LT . Large-dose intravenous ferric carboxymaltose injection for iron deficiency anemia in heavy uterine bleeding: a randomized, controlled trial. Transfusion 2009; 49: 2719–2728.

    Article  CAS  Google Scholar 

  2. Hussain I, Bhoyroo J, Butcher A, Koch TA, He A, Bregman DB . Direct comparison of the safety and efficacy of ferric carboxymaltose versus iron dextran in patients with iron deficiency anemia. Anemia 2013; 2013: 169107.

    Article  Google Scholar 

  3. Wolf M, Koch TA, Bregman DB . Effects of iron deficiency anemia and its treatment on fibroblast growth factor 23 and phosphate homeostasis in women. J Bone Miner Res 2013; 28: 1793–1803.

    Article  CAS  Google Scholar 

  4. Mani LY, Nseir G, Venetz JP, Pascual M . Severe hypophosphatemia after intravenous administration of iron carboxymaltose in a stable renal transplant recipient. Transplantation 2010; 90: 804–805.

    Article  Google Scholar 

  5. Subramanian R, Khardori R . Severe hypophosphatemia. Pathophysiologic implications, clinical presentations, and treatment. Medicine (Baltimore) 2000; 79: 1–8.

    Article  CAS  Google Scholar 

  6. Vaucher P, Druais PL, Waldvogel S, Favrat B . Effect of iron supplementation on fatigue in nonanemic menstruating women with low ferritin: a randomized controlled trial. CMAJ 2012; 184: 1247–1254.

    Article  Google Scholar 

  7. Schouten BJ, Hunt PJ, Livesey JH, Frampton CM, Soule SG . FGF23 elevation and hypophosphatemia after intravenous iron polymaltose: a prospective study. J Clin Endocrinol Metab 2009; 94: 2332–2337.

    Article  CAS  Google Scholar 

  8. Hu MC, Shiizaki K, Kuro-o M, Moe OW . Fibroblast growth factor 23 and Klotho: physiology and pathophysiology of an endocrine network of mineral metabolism. Annu Rev Physiol 2013; 75: 503–533.

    Article  CAS  Google Scholar 

  9. Okada M, Imamura K, Iida M, Fuchigami T, Omae T . Hypophosphatemia induced by intravenous administration of saccharated iron oxide. Klin Wochenschr 1983; 61: 99–102.

    Article  CAS  Google Scholar 

  10. Vadhan-Raj S, Strauss W, Ford D, Bernard K, Boccia R, Li J, Allen LF . Efficacy and safety of IV ferumoxytol for adults with iron deficiency anemia previously unresponsive to or unable to tolerate oral iron. Am J Hematol 2013; 89: 7–12.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations


Corresponding author

Correspondence to P Coti Bertrand.

Ethics declarations

Competing interests

The authors declare no conflict of interest.

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Fierz, Y., Kenmeni, R., Gonthier, A. et al. Severe and prolonged hypophosphatemia after intravenous iron administration in a malnourished patient. Eur J Clin Nutr 68, 531–533 (2014).

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI:

This article is cited by


Quick links